Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma

This study is currently recruiting participants.

Study NCT00670358 Information provided by National Cancer Institute (NCI)

First Received: April 30, 2008 Last Updated: August 4, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)